Massachusetts Biotech Funding Sees Divergent Trends as Early-Stage Investment Wanes Amid Rising China Competition
admin A recent comprehensive report by MassBio, a prominent trade organization representing the Massachusetts life sciences...
admin
CureSearch Awards Two Million Dollars to Washington University for Innovative Pediatric Brain Cancer Immunotherapy Trial
In a significant move to address one of the most challenging frontiers in pediatric medicine,...
FDA extends review of Capricor cell therapy; Pain drug startup to go public
Washington D.C. – August 24, 2026 – The biopharmaceutical landscape is abuzz with significant regulatory...
Luke’s Legacy: The Urgent Call for Less Toxic Pediatric Cancer Treatments Amidst the Realities of Acute Myeloid Leukemia
The devastating trajectory of pediatric Acute Myeloid Leukemia (AML) has been brought into sharp focus...
Advancing the Fight Against Sarcoma: Immunotherapy’s Evolving Role in a Rare and Complex Cancer
Sarcoma, a rare and complex group of cancers originating in the body’s connective tissues, presents...
Regenxbio’s RGX-121 Gene Therapy for Hunter Syndrome Faces New Clinical Hold Amidst Troubled Regulatory Path
The development journey for RGX-121, Regenxbio’s investigational gene therapy designed as a one-time treatment for...
Lauren Kate’s Courageous Battle with B-Cell Acute Lymphoblastic Leukemia and the Intersection of Down Syndrome and Pediatric Oncology
The medical community and the American Childhood Cancer Organization (ACCO) have recently highlighted the resilience...
Walk by Faith Gala Raises Over One Hundred Thousand Dollars to Support Childhood Cancer Programs and Honor the Legacy of the Nelson Sisters
The landscape of downtown St. Paul, Minnesota, served as the backdrop for a significant philanthropic...
Meet the 2026 CureSearch Community Impact Award Recipients
The landscape of pediatric oncology is undergoing a significant transformation as CureSearch for Children’s Cancer,...
FDA Grants Accelerated Approval to Tudriqev, Marking a Decade-Plus Milestone in Oncolytic Virus Therapy for Advanced Melanoma
The U.S. Food and Drug Administration (FDA) has announced the accelerated approval of Tudriqev (vusolimogene...
